Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan. 2021

Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
National Centre for Chemical Products, Cosmetics and Consumer Protection, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Furan is a volatile compound that is formed in foods during thermal processing. It is classified as a possible human carcinogen by international authorities based on sufficient evidence of carcinogenicity from studies in experimental animals. Although a vast number of studies both in vitro and in vivo have been performed to investigate furan genotoxicity, the results are inconsistent, and its carcinogenic mode of action remains to be clarified. Here, we address the mutagenic and clastogenic activity of furan and its prime reactive metabolite cis-2 butene-1,4-dial (BDA) in mammalian cells in culture and in mouse animal models in a search for DNA lesions responsible of these effects. To this aim, Fanconi anemia-derived human cell lines defective in the repair of DNA inter-strand crosslinks (ICLs) and Ogg1-/- mice defective in the removal of 8-hydroxyguanine from DNA, were used. We show that both furan and BDA present a weak (if any) mutagenic activity but are clear inducers of clastogenic damage. ICLs are strongly indicated as key lesions for chromosomal damage whereas oxidized base lesions are unlikely to play a critical role.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans

Related Publications

Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
June 2004, Mutation research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
September 1997, Mutation research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
October 2008, Leukemia,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
September 1977, Radiation research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
April 2020, IET nanobiotechnology,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
March 1990, Mutagenesis,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
February 1993, Mutation research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
May 1991, Biological trace element research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
July 1974, Mutation research,
Maria Teresa Russo, and Gabriele De Luca, and Nieves Palma, and Paola Leopardi, and Paolo Degan, and Serena Cinelli, and Gaetano Pepe, and Pasquale Mosesso, and Emma Di Carlo, and Carlo Sorrentino, and Piero Musiani, and Riccardo Crebelli, and Margherita Bignami, and Eugenia Dogliotti
February 2011, Mutation research,
Copied contents to your clipboard!